Quantitative Co-clinical Imaging Trial to Assess Drug Response

This session wil provide insight on how pre-clinical development of quantitative imaging biomarkers can help tailor clinical drug trials.  These pan- imaging modality scientific endeavors will focus on assessing response to therapy in solid tumors. The three exemplary projects presented here will also highlight the resources developed such as experimental design, protocol and software development, modeling and information extraction, biological and pathological validations, multiscale data integration, and preclinical–clinical correlations.

Session Agenda
1) Overview of all CIRP projects at high level
2) Selected examples of completed or nearly completed CIRP projects/resources
3) Overview of proposed roadmap to the future